Alimera Sciences Inc (NASDAQ: ALIM) rallied a whopping 75% in premarket today after ANI Pharmaceuticals Inc (NASDAQ: ANIP) said it will buy the Alpharetta, Georgia based company for about $381 million. Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.ANI shares are roughly flat at writing.  Alimera Sciences stock valued at a 75% premiumCopy link to sectionANI Pharmaceuticals is willing to pay $5.50 in cash for each share of Alimera Sciences. It has als ...